Tolerability and Effectiveness of Exenatide Once Weekly Relative to Basal Insulin Among Type 2 Diabetes Patients of Different Races in Routine Care

Anthony P. Nunes; Anita M. Loughlin; Qing Qiao; Stephen M. Ezzy; Laura Yochum; C. Robin Clifford; Robert V. Gately; David D. Dore; John D. Seeger

doi:10.1007/s13300-017-0314-z

Tolerability and Effectiveness of Exenatide Once Weekly Relative to Basal Insulin Among Type 2 Diabetes Patients of Different Races in Routine Care

Diabetes Therapy ◽

10.1007/s13300-017-0314-z ◽

2017 ◽

Vol 8 (6) ◽

pp. 1349-1364 ◽

Cited By ~ 2

Author(s):

Anthony P. Nunes ◽

Anita M. Loughlin ◽

Qing Qiao ◽

Stephen M. Ezzy ◽

Laura Yochum ◽

...

Keyword(s):

Type 2 Diabetes ◽

Basal Insulin ◽

Routine Care ◽

Diabetes Patients

Download Full-text

Basal insulin or premix analogue therapy in type 2 diabetes patients

European Journal of Internal Medicine ◽

10.1016/j.ejim.2006.09.006 ◽

2007 ◽

Vol 18 (1) ◽

pp. 56-62 ◽

Cited By ~ 35

Author(s):

Philip R. Raskin ◽

Priscilla A. Hollander ◽

Andrew Lewin ◽

Robert A. Gabbay ◽

Bruce Bode ◽

...

Keyword(s):

Type 2 Diabetes ◽

Basal Insulin ◽

Diabetes Patients

Download Full-text

Considerations for Insulin-Treated Type 2 Diabetes Patients During Hospitalization: A Narrative Review of What We Need to Know in the Age of Second-Generation Basal Insulin Analogs

Diabetes Therapy ◽

10.1007/s13300-020-00920-z ◽

2020 ◽

Vol 11 (12) ◽

pp. 2775-2790

Author(s):

Sherwin C. D’Souza ◽

Davida F. Kruger

Keyword(s):

Type 2 Diabetes ◽

Basal Insulin ◽

Second Generation ◽

Narrative Review ◽

Insulin Analogs ◽

Diabetes Patients

Download Full-text

The Durability of Basal Insulin Affects Day-to-Day Glycemic Variability Assessed by Continuous Glucose Monitoring in Type 2 Diabetes Patients: A Randomized Crossover Trial

Diabetes Technology & Therapeutics ◽

10.1089/dia.2017.0028 ◽

2017 ◽

Vol 19 (8) ◽

pp. 457-462 ◽

Cited By ~ 8

Author(s):

Hiroyuki Iuchi ◽

Masaya Sakamoto ◽

Daisuke Matsutani ◽

Hirofumi Suzuki ◽

Ryuzo Horiuchi ◽

...

Keyword(s):

Type 2 Diabetes ◽

Continuous Glucose Monitoring ◽

Basal Insulin ◽

Crossover Trial ◽

Glucose Monitoring ◽

Glycemic Variability ◽

Randomized Crossover Trial ◽

Diabetes Patients

Download Full-text

The Costs of Intensifying Type 2 Diabetes Patients Treated with Basal Insulin to Basal in Combination with GLP-1: A Physician Survey

Value in Health ◽

10.1016/j.jval.2018.04.495 ◽

2018 ◽

Vol 21 ◽

pp. S74

Author(s):

KM Pfeiffer ◽

A Basse ◽

M Brod

Keyword(s):

Type 2 Diabetes ◽

Basal Insulin ◽

Physician Survey ◽

Diabetes Patients

Download Full-text

Achievement of Target A1C <7.0% (<53 mmol/mol) by U.S. Type 2 Diabetes Patients Treated With Basal Insulin in Both Randomized Controlled Trials and Clinical Practice

Diabetes Spectrum ◽

10.2337/ds17-0082 ◽

2018 ◽

Vol 32 (2) ◽

pp. 93-103 ◽

Cited By ~ 1

Author(s):

Lawrence Blonde ◽

Stephen A. Brunton ◽

Pavan Chava ◽

Rong Zhou ◽

Juliana Meyers ◽

...

Keyword(s):

Type 2 Diabetes ◽

Clinical Practice ◽

Randomized Controlled Trials ◽

Basal Insulin ◽

Controlled Trials ◽

Randomized Controlled ◽

Diabetes Patients

Download Full-text

Medication Review by Community Pharmacists for Type 2 Diabetes Patients in Routine Care: Results of the DIATHEM-Study

Frontiers in Pharmacology ◽

10.3389/fphar.2020.01176 ◽

2020 ◽

Vol 11 ◽

Cited By ~ 1

Author(s):

Elisabeth Schindler ◽

Carina Hohmann ◽

Carsten Culmsee

Keyword(s):

Type 2 Diabetes ◽

Medication Review ◽

Community Pharmacists ◽

Routine Care ◽

Diabetes Patients

Download Full-text

Medical Costs of Hypoglycemia in Type 1 and Type 2 Diabetes Patients Using Basal Insulin Analogues in China: Based on Medical Record Data

Value in Health ◽

10.1016/j.jval.2018.07.287 ◽

2018 ◽

Vol 21 ◽

pp. S38

Author(s):

Z Ruan ◽

CO Ung ◽

L Li ◽

H Hu

Keyword(s):

Type 2 Diabetes ◽

Medical Record ◽

Basal Insulin ◽

Medical Costs ◽

Insulin Analogues ◽

Medical Record Data ◽

Record Data ◽

Diabetes Patients

Download Full-text

Indirect comparison of efficacy and safety of insulin glargine/lixisenatide and insulin degludec/insulin aspart in type 2 diabetes patients not controlled on basal insulin

Primary Care Diabetes ◽

10.1016/j.pcd.2020.08.004 ◽

2021 ◽

Vol 15 (1) ◽

pp. 132-137

Author(s):

Anwar Ali Jammah

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Insulin Aspart ◽

Basal Insulin ◽

Indirect Comparison ◽

Insulin Degludec ◽

Efficacy And Safety ◽

Diabetes Patients

Download Full-text

Cardiovascular safety of long-acting insulin analogs in type 2 diabetes patients: Is there a better basal insulin?

Journal of Diabetes Investigation ◽

10.1111/jdi.12776 ◽

2017 ◽

Vol 9 (4) ◽

pp. 728-730 ◽

Cited By ~ 3

Author(s):

Chia-Hsuin Chang ◽

Lee-Ming Chuang

Keyword(s):

Type 2 Diabetes ◽

Basal Insulin ◽

Cardiovascular Safety ◽

Insulin Analogs ◽

Acting Insulin ◽

Long Acting ◽

Diabetes Patients

Download Full-text

Diabetes Management and Healthcare Resource Use When Intensifying from Basal Insulin to Basal-Bolus: A Survey of Type 2 Diabetes Patients

Diabetes Therapy ◽

10.1007/s13300-018-0487-0 ◽

2018 ◽

Vol 9 (5) ◽

pp. 1931-1944 ◽

Cited By ~ 4

Author(s):

Kathryn M. Pfeiffer ◽

Amaury Basse ◽

Xin Ying Lee ◽

Laura Tesler Waldman

Keyword(s):

Type 2 Diabetes ◽

Resource Use ◽

Basal Insulin ◽

Diabetes Management ◽

Healthcare Resource ◽

Healthcare Resource Use ◽

Basal Bolus ◽

Diabetes Patients

Download Full-text